Prostaglandin E2 receptors as therapeutic targets in renal fibrosis
Prostaglandin E2 (PGE2), a lipid mediator produced by the cyclooxygenase enzyme system, is the main prostaglandin in the kidney. PGE2 is involved in various physiological and pathophysiological processes in the kidney, including renal hemodynamics, water and salt balance, and renal fibrosis-a key pa...
Saved in:
Main Authors: | Henricus A.M. Mutsaers (Author), Rikke Nørregaard (Author) |
---|---|
Format: | Book |
Published: |
The Korean Society of Nephrology,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phenformin Attenuates Renal Injury in Unilateral Ureteral Obstructed Mice without Affecting Immune Cell Infiltration
by: Mikkel Ø. Nørgård, et al.
Published: (2020) -
Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidney
by: Rikke Nørregaard, et al.
Published: (2015) -
Predictive Value of Precision-Cut Kidney Slices as an Ex Vivo Screening Platform for Therapeutics in Human Renal Fibrosis
by: Emilia Bigaeva, et al.
Published: (2020) -
15-Deoxy-Δ12,14-prostaglandin J2 Exerts Antioxidant Effects While Exacerbating Inflammation in Mice Subjected to Ureteral Obstruction
by: Line Nilsson, et al.
Published: (2017) -
Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis
by: Greg H. Tesch, et al.
Published: (2017)